About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Venlafaxine Hydrochloride
- Company
- Norwegian University of Science and Technology
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 18 recruiting
Efficacy results: Not yet reported
18 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 15, 2026
Find a Clinical Trial Near Me
See recruiting studies for Venlafaxine Hydrochloride and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT03511118
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Duke University 1600 participants Est. completion 2028-07-31 22 sitesOther conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOIView official trial listing → -
Recruiting NCT NCT03532477
Bariatric Surgery and Pharmacokinetics of Venlafaxine
Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 siteOther conditions: Obesity, MorbidView official trial listing → -
Recruiting NCT NCT04539951
Pragmatic Trial of Obsessive-compulsive Disorder
Not yet reported Shanghai Mental Health Center 1600 participants Est. completion 2028-12-31 1 siteOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Recruiting NCT NCT05603104
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Not yet reported Dr. Inge Winter 1254 participants Est. completion 2028-06-30 1 site Stand-aloneOther conditions: Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar DepressionView official trial listing → -
Recruiting NCT NCT05830279
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 600 participants Est. completion 2026-04-30 1 siteOther conditions: Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive, Cancer PainView official trial listing → -
Recruiting NCT NCT05973786
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Not yet reported Dr. Inge Winter 418 participants Est. completion 2028-06-30 13 sites Stand-aloneOther conditions: Bipolar DepressionView official trial listing → -
Recruiting NCT NCT06106529
REDucing Hot FLASHes in Women Using Endocrine Therapy.
Not yet reported Reinier de Graaf Groep 260 participants Est. completion 2029-01-01 1 site Stand-aloneOther conditions: Breast Cancer, Hot Flash Due to MedicationView official trial listing → -
Recruiting NCT NCT06508710
Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2026-04 4 sites Stand-aloneOther conditions: Major Depressive EpisodeView official trial listing → -
Recruiting NCT NCT06591091
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
Not yet reported University of Illinois at Chicago 80 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Recruiting NCT NCT06803485
Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 84 participants Est. completion 2026-11 1 site Stand-aloneOther conditions: Somatic Symptom Disorder (DSM-V)View official trial listing → -
Recruiting NCT NCT07025590
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
Not yet reported Guangdong Provincial People's Hospital 106 participants Est. completion 2027-03-31 1 siteCardiovascular disease Other conditions: Depression Anxiety DisorderView official trial listing → -
Recruiting NCT NCT07120880
Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia
Not yet reported Assistance Publique - Hôpitaux de Paris 184 participants Est. completion 2029-01 1 siteOther conditions: Major Depressive Disorder (MDD) With InsomniaView official trial listing → -
Recruiting NCT NCT07186751
The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
Not yet reported Beijing Tiantan Hospital 750 participants Est. completion 2027-08-31 2 sites Stand-aloneOther conditions: Fibromyalgia, Pregabalin, Venlafaxine, PainView official trial listing → -
Recruiting NCT NCT07230171
The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia
Not yet reported Beijing Tiantan Hospital 92 participants Est. completion 2027-08-31 1 site Stand-aloneOther conditions: Fibromyalgia, Pregabalin, EsketamineView official trial listing → -
Recruiting NCT NCT07328373
Neurobiological and Genomic Predictors of Relapse in Depression
Mehmet Kemal Arikan 204 participants Est. completion 2027-02-01 1 siteOther conditions: Healthy, Major Depressive Disorder (MDD)View official trial listing → -
Recruiting NCT NCT07330648
Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder
Not yet reported Anhui Medical University 216 participants Est. completion 2027-02-28 1 site Stand-aloneOther conditions: Generalized Anxiety DisorderView official trial listing → -
Recruiting NCT NCT07361796
The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster
Not yet reported Beijing Tiantan Hospital 832 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Herpes Zoster, Pain, Postherpetic NeuralgiaView official trial listing → -
Recruiting NCT NCT07361809
The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster
Not yet reported Beijing Tiantan Hospital 750 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Herpes Zoster, PainView official trial listing → -
Completed NCT NCT00001478
Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
National Institute of Mental Health (NIMH) 170 participants Est. completion 2001-01 1 siteOther conditions: Healthy, Mood DisordersView official trial listing → -
Completed NCT NCT00001483
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
Not yet reported National Institute of Mental Health (NIMH) 75 participants Est. completion 2002-05 1 siteOther conditions: Bipolar Disorder, Depressive DisorderView official trial listing → -
Completed NCT NCT00018902
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
Not yet reported, Not yet reported University of Pittsburgh 334 participants Est. completion 2007-03 6 sites Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00030914
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
Not yet reported Alliance for Clinical Trials in Oncology 227 participants Est. completion 2006-09 22 sites Stand-aloneOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT00038896
Study Evaluating Venlafaxine ER in Adults With Panic Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 343 participants Est. completion 2002-12Other conditions: Panic DisorderView official trial listing → -
Completed NCT NCT00043550
Treatments for Depression: Drug Versus Psychotherapy
Not yet reported University of Pennsylvania 156 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00044772
Study Evaluating Venlafaxine ER in Patients With Panic Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 653 participants Est. completion 2003-04Other conditions: Panic DisorderView official trial listing → -
Completed NCT NCT00045916
Optimizing Electroconvulsive Therapy for Depression
Not yet reported New York State Psychiatric Institute 340 participants Est. completion 2006-12 4 sites Stand-aloneOther conditions: Depression, Depressive Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00046020
Study Evaluating Venlafaxine ER in Recurrent Depression
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1096 participants Est. completion 2005-10Other conditions: Depressive Disorder, Major, RecurrenceView official trial listing → -
Completed NCT NCT00057551
Research Evaluating the Value of Augmenting Medication With Psychotherapy
Not yet reported Weill Medical College of Cornell University 491 participants Est. completion 2007-03 8 sites Stand-aloneOther conditions: Depression, Depressive DisorderView official trial listing → -
Completed NCT NCT00057642
Improving Retention of Hispanics Receiving Antidepressant Therapy
Not yet reported New York State Psychiatric Institute 50 participants Est. completion 2006-08 1 siteOther conditions: Depression, Depressive DisorderView official trial listing → -
Completed NCT NCT00067912
Duloxetine vs. Active Comparator for the Treatment of Depression
Not yet reported Eli Lilly and Company 480 participants Est. completion 2004-03 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00071695
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
Not yet reported Eli Lilly and Company 320 participants Est. completion 2004-05 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00074815
Treatment of Obsessive Compulsive Disorder in Children
Not yet reported Duke University 124 participants Est. completion 2009-11 3 sitesOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Completed NCT NCT00080158
Treatment of Adolescent Suicide Attempters (TASA)
Not yet reported, Not yet reported New York State Psychiatric Institute 120 participants Est. completion 2007-06 6 sitesOther conditions: Depression, Suicide, AttemptedView official trial listing → -
Terminated NCT NCT00083980
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Not yet reported National Center for Complementary and Integrative Health (NCCIH) 16 participants Est. completion 2004-08Other conditions: Anxiety DisordersView official trial listing → -
Completed NCT NCT00084669
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer
Not yet reported Massachusetts General Hospital 119 participants Est. completion 2010-03 2 sitesOther conditions: Breast Cancer, Hot Flashes, Sleep DisordersView official trial listing → -
Completed NCT NCT00086190
Study of Antidepressants in Parkinson's Disease
Not yet reported University of Rochester 115 participants Est. completion 2009-11 18 sitesOther conditions: Parkinson Disease, DepressionView official trial listing → -
Completed NCT NCT00087737
Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 369 participants Est. completion 2005-05Other conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00090649
Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 369 participants Est. completion 2005-03Other conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00115362
Serotonin Effect in Functional Dyspepsia
Not yet reported Radboud University Medical Center 300 participants Est. completion 2007-07 6 sitesOther conditions: DyspepsiaView official trial listing → -
Completed NCT NCT00118430
Stepped Care for Depression and Musculoskeletal Pain
Not yet reported Indiana University 500 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Pain, DepressionView official trial listing → -
Completed NCT NCT00122837
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Not yet reported Eli Lilly and Company 560 participants Est. completion 2007-01 22 sitesOther conditions: Anxiety DisorderView official trial listing → -
Completed NCT NCT00122850
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Not yet reported Eli Lilly and Company 480 participants Est. completion 2005-11 19 sitesOther conditions: Anxiety DisordersView official trial listing → -
Completed NCT NCT00129467
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
Not yet reported US Department of Veterans Affairs 47 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Depression, Palliative Care, Cancer, Mental DisorderView official trial listing → -
Completed NCT NCT00131456
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
Not yet reported New York State Psychiatric Institute 123 participants Est. completion 2010-12 1 siteOther conditions: Depression, Marijuana AbuseView official trial listing → -
Completed NCT NCT00150839
Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy
Not yet reported University of Erlangen-Nürnberg Medical School 80 participants Est. completion 2009-12 1 siteOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00151450
Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 390 participants Est. completion 2006-11 45 sitesOther conditions: AnxietyView official trial listing → -
Completed NCT NCT00157547
Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
Not yet reported Massachusetts General Hospital 95 participants Est. completion 2006-08Other conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT00159146
Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression
Not yet reported Hillerod Hospital, Denmark 31 participants Est. completion 2007-09 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT00167856
Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury
Not yet reported US Department of Veterans Affairs 16 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Neuropathic Pain, Pain, Spinal Cord InjuriesView official trial listing → -
Completed NCT NCT00177528
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
Not yet reported University of Pittsburgh 70 participants 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00177567
Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
Not yet reported University of Pittsburgh 60 participants Est. completion 2004-01 2 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00177671
Antidepressant Medication Plus Donepezil for Treating Late-life Depression
Not yet reported University of Pittsburgh 220 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Depression, DementiaView official trial listing → -
Completed NCT NCT00179283
Sertraline vs. Venlafaxine XR
Not yet reported Vanderbilt University 20 participants Est. completion 2003-04 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00183274
Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
Not yet reported University of Pennsylvania 268 participants Est. completion 2009-09 1 siteOther conditions: Anxiety DisordersView official trial listing → -
Completed NCT NCT00186264
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
Not yet reported Stanford University 18 participants Est. completion 2006-04 1 siteOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00188643
Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression
Not yet reported University Health Network, Toronto 40 participants Est. completion 2007-01 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00195598
Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 70 participants Est. completion 2006-04 4 sitesOther conditions: Panic DisordersView official trial listing → -
Completed NCT NCT00198250
Venlafaxine for Hot Flashes After Breast Cancer
Not yet reported Indiana University 75 participants Est. completion 2005-11 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00200902
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
Not yet reported University of California, Los Angeles 88 participants Est. completion 2009-06 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00205491
Pharmacological Intervention in Depression After Traumatic Brain Injury
Not yet reported Virginia Commonwealth University 100 participants Est. completion 2007-09 1 siteOther conditions: TBI (Traumatic Brain Injury)View official trial listing → -
Terminated NCT NCT00211809
CBT as an Adjunct to SRIs in the Treatment of BDD
Not yet reported Icahn School of Medicine at Mount Sinai 17 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Body Dysmorphic DisorderView official trial listing → -
Completed NCT NCT00225485
Study Evaluating Effexor XR in Elderly Patients With Major Depression.
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 100 participants 37 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT00225511
Study Evaluating Effexor XR for Major Depression.
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 590 participants 73 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT00225524
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants 73 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT00238719
Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 293 participants Est. completion 2003-06Other conditions: Social Anxiety DisorderView official trial listing → -
Completed NCT NCT00247429
Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
Wyeth is now a wholly owned subsidiary of Pfizer 59 participants Est. completion 2005-10Other conditions: Depressive Syndrome, AnxietyView official trial listing → -
Completed NCT NCT00248612
Psychosocial and Medication Treatment for Anxiety in Alcoholism
Not yet reported, Not yet reported Boston Medical Center 162 participants Est. completion 2009-03 2 sites Stand-aloneOther conditions: Alcohol-Related Disorders, Anxiety DisordersView official trial listing → -
Completed NCT NCT00249483
Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals
Not yet reported New York State Psychiatric Institute 150 participants Est. completion 2005-02 1 site Stand-aloneOther conditions: Cocaine-Related DisordersView official trial listing → -
Completed NCT NCT00253266
Venlafaxine Augmentation in Treatment Resistant Depression
Not yet reported Max-Planck-Institute of Psychiatry 126 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00282828
Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
Not yet reported Massachusetts General Hospital 397 participants Est. completion 2011-12 3 sites Stand-aloneOther conditions: Social PhobiaView official trial listing → -
Completed NCT NCT00316160
Sexual Functioning Study With Antidepressants
Not yet reported GlaxoSmithKline 347 participants Est. completion 2005-05 45 sitesOther conditions: Depressive Disorder, Major, Major Depressive Disorder (MDD)View official trial listing → -
Completed NCT NCT00329186
Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 14 participants Est. completion 2007-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00351910
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
Not yet reported AstraZeneca 494 participants Est. completion 2007-04 72 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Not yet reported Wake Forest University Health Sciences 120 participants Est. completion 2010-08-01 20 sites Stand-aloneOther conditions: Hot Flashes, Prostate CancerView official trial listing → -
Completed NCT NCT00362271
Aripiprazole and Effexor XR Drug Interaction Study
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 38 participants Est. completion 2006-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00386243
Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)
Not yet reported VA Office of Research and Development 242 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: Low Back Pain, Pain, Pain, IntractableView official trial listing → -
Completed NCT NCT00401726
Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 537 participants Est. completion 2007-10 44 sitesOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00435279
A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
Not yet reported Sumitomo Pharma America, Inc. 678 participants Est. completion 2009-07 69 sites Stand-aloneOther conditions: Major Depressive Disorder, InsomniaView official trial listing → -
Completed NCT NCT00448058
A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
Not yet reported GlaxoSmithKline 396 participants Est. completion 2008-12 42 sitesOther conditions: Depressive DisorderView official trial listing → -
Completed NCT NCT00474708
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1151 participants Est. completion 2008-03 26 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00546494
Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 350 participants Est. completion 2005-03Other conditions: DepressionView official trial listing → -
Completed NCT NCT00546923
Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 210 participants Est. completion 2006-06Other conditions: Anxiety Disorders, DepressionView official trial listing → -
Completed NCT NCT00564278
Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression
Not yet reported New York State Psychiatric Institute 217 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00584974
A Safety, Efficacy and Tolerability Study of SEP-225289
Not yet reported Sumitomo Pharma America, Inc. 523 participants Est. completion 2009-05 51 sitesOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00590863
Combining Medications to Enhance Depression Outcomes
Not yet reported National Institute of Mental Health (NIMH) 665 participants Est. completion 2009-09 15 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00592384
Project to Improve Symptoms and Mood in People With Spinal Cord Injury
Not yet reported University of Washington 133 participants Est. completion 2012-09 6 sites Stand-aloneOther conditions: Major Depressive Disorder, Dysthymia, Spinal Cord InjuriesView official trial listing → -
Completed NCT NCT00602537
Antidepressant Therapy in Treating Bipolar Type II Major Depression
Not yet reported University of Pennsylvania 140 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Bipolar Disorder, DepressionView official trial listing → -
Completed NCT NCT00611676
A Single-Blind Placebo Run-In Study of Venlafaxine for Activity-Limiting Osteoarthritis Pain
Not yet reported University of Washington 18 participants Est. completion 2007-02 Stand-aloneOsteoarthritis Other conditions: PainView official trial listing → -
Completed NCT NCT00612807
Treatment of Mood and Marriage Study (TOMMS)
Not yet reported, Not yet reported Duke University 42 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Major Depressive Disorder, Partner Relational Disorder (V61.10)View official trial listing → -
Completed NCT NCT00620776
Combined Treatment for Generalized Anxiety Disorder (GAD)
Not yet reported University of Pennsylvania 69 participants Est. completion 2008-03 1 site Stand-aloneOther conditions: Generalized Anxiety DisorderView official trial listing → -
Completed NCT NCT00627887
Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression
Not yet reported Örebro County Council 56 participants Est. completion 2012-05 4 sites Stand-aloneOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00634283
Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects
Not yet reported University of California, Los Angeles 6 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00641927
Antidepressant Therapy for Bipolar II Major Depression
Not yet reported Stanley Medical Research Institute 90 participants Est. completion 2006-10 1 site Stand-aloneOther conditions: Bipolar Type II DisorderView official trial listing → -
Completed NCT NCT00644982
A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 163 participants Est. completion 2003-09 14 sites Stand-aloneOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00667121
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic 88 participants Est. completion 2014-05-27 6 sitesOther conditions: Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its TreatmentView official trial listing → -
Completed NCT NCT00676039
Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations
Not yet reported University of Ottawa 18 participants Est. completion 2008-07 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT00693849
International Study to Predict Optimised Treatment - in Depression
Not yet reported BRC Operations Pty. Ltd. 2688 participants Est. completion 2019-12 20 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00704860
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism
Not yet reported University of Ottawa 27 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT00714090
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
Not yet reported Club rTMS et Psychiatrie 170 participants Est. completion 2013-07 18 sites Stand-aloneOther conditions: Unipolar DepressionView official trial listing → -
Completed NCT NCT00727064
Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 14 participants Est. completion 2008-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00735670
Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury
Not yet reported University of Michigan 34 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Spinal Cord InjuryView official trial listing → -
Completed NCT NCT00742573
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
Not yet reported New York State Psychiatric Institute 170 participants Est. completion 2014-01-10 1 site Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00744406
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
Not yet reported Centre for Addiction and Mental Health 72 participants 1 site Stand-aloneOther conditions: Depression, Major Depressive DisorderView official trial listing → -
Completed NCT NCT00745017
Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
Not yet reported Centre for Addiction and Mental Health 72 participants 1 site Stand-aloneOther conditions: Depression, Major Depressive DisorderView official trial listing → -
Completed NCT NCT00759122
Electroencephalography (EEG) Biomarkers of Response in Depression
Not yet reported University of California, Los Angeles 44 participants Est. completion 2005-12 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00759317
Physiologic Monitoring of Antidepressant Treatment Response
Not yet reported University of California, Los Angeles 37 participants Est. completion 2002-09 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00763724
Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults
Eli Lilly and Company 254432 participants Est. completion 2009-11Other conditions: Depression, SuicideView official trial listing → -
Terminated NCT NCT00766870
Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder
Not yet reported H. Lundbeck A/S 35 participants Est. completion 2009-02 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00782964
Antidepressant Incomplete Response Depression
AstraZeneca 364 participants Est. completion 2009-11 48 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00788944
Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 971 participants Est. completion 2009-07 52 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT00789854
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
Not yet reported AstraZeneca 688 participants Est. completion 2009-08 106 sitesOther conditions: Major Depressive Disorder, Treatment Resistant DepressionView official trial listing → -
Completed NCT NCT00792168
Physiologic Monitoring of Antidepressant Response
Not yet reported University of California, Los Angeles 38 participants Est. completion 1998-12 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT00797966
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 850 participants Est. completion 2010-07 50 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT00817011
Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Not yet reported Samsung Medical Center 1000 participants Est. completion 2018-03 1 siteOther conditions: Depression, Antidepressant Drug Adverse ReactionView official trial listing → -
Status unknown NCT NCT00817375
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Not yet reported Samsung Medical Center 1000 participants Est. completion 2018-12 1 siteOther conditions: Depression, Adverse Reaction to DrugView official trial listing → -
Completed NCT NCT00834249
Venlafaxine 25 mg Tablets Under Non-Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 18 participants Est. completion 2002-12 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00834964
Venlafaxine 25 mg Tablets Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 30 participants Est. completion 2002-12 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00839423
Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
Not yet reported H. Lundbeck A/S 426 participants Est. completion 2007-09Other conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00854100
Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
Not yet reported Forest Laboratories 231 participants Est. completion 2010-12-06 41 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00871364
A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions
Not yet reported Actavis Inc. 30 participants Est. completion 2006-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT00878748
Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2011-10 Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00892047
Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)
Not yet reported University of Pittsburgh 468 participants Est. completion 2014-09 3 sites Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT00909155
Brain Imaging Techniques That Predict Antidepressant Responsiveness
Not yet reported University of Wisconsin, Madison 50 participants Est. completion 2009-12 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT00926835
Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
Not yet reported Ministry of Health & Welfare, Korea 692 participants Est. completion 2015-07 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00944996
Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
Not yet reported Tirat Carmel Mental Health Center 100 participants Est. completion 2012-07 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT00967707
Population Pharmacokinetic-pharmacodynamic (PK-PD) Modeling of Co-administered Gabapentin in Neuropathic Pain
Not yet reported Uppsala University 30 participants Est. completion 2011-09 1 siteOther conditions: Post-traumatic Neuropathic PainView official trial listing → -
Completed NCT NCT00974155
The Early Medication Change (EMC) Trial
Not yet reported K. Lieb 889 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT01000623
Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes
Not yet reported Mayo Clinic 71 participants Est. completion 2015-09-08 1 site Stand-aloneOther conditions: Hot FlashesView official trial listing → -
Completed NCT NCT01011751
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
Not yet reported Takeda 311 participants Est. completion 2007-12 1 site Stand-aloneOther conditions: Adenocarcinoma, ProstateView official trial listing → -
Completed NCT NCT01028508
Prolonging Remission in Depressed Elderly (PRIDE)
Not yet reported Icahn School of Medicine at Mount Sinai 247 participants Est. completion 2016-03 10 sitesOther conditions: DepressionView official trial listing → -
Terminated NCT NCT01114698
A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder
Not yet reported Janssen Research & Development, LLC 12 participants Est. completion 2012-02 14 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT01124188
ADAPT: Addressing Depression and Pain Together
Not yet reported University of Pittsburgh 263 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Depression, Back PainView official trial listing → -
Status unknown NCT NCT01204086
Pharmacogenomics Studies of Antidepressants
Not yet reported National Cheng-Kung University Hospital 200 participants Est. completion 2011-02 1 site Stand-aloneOther conditions: Major Depressive Disorder, Antidepressive Agents, Pharmacogenetics, Venlafaxine, FluoxetineView official trial listing → -
Status unknown NCT NCT01228357
Predict Antidepressant Responsiveness Using Pharmacogenomics
Not yet reported Samsung Medical Center 1000 participants Est. completion 2018-12 1 siteOther conditions: Depression, Depressive SymptomsView official trial listing → -
Completed NCT NCT01235338
Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers
Not yet reported Shire 80 participants Est. completion 2011-01-17 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01260896
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2002-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01282801
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions
Not yet reported Teva Pharmaceuticals USA 18 participants Est. completion 2002-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01282814
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2003-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01305707
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Not yet reported Hospital Universitari de Bellvitge 104 participants Est. completion 2014-07 3 sitesOther conditions: DepressionView official trial listing → -
Completed NCT NCT01350921
Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers
Not yet reported AstraZeneca 22 participants Est. completion 2012-03 2 sitesOther conditions: Drug Drug InteractionView official trial listing → -
Status unknown NCT NCT01352572
Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
Not yet reported Samsung Medical Center 300 participants Est. completion 2018-12 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT01360866
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 2944 participants Est. completion 2017-05-18 142 sites Stand-aloneOther conditions: Depressive Disorder, Depression, Depressive Disorder, Major, Mood Disorders, Mental DisordersView official trial listing → -
Status unknown NCT NCT01369290
Electroencephalography (EEG) Signal Processing
St. Joseph's Healthcare Hamilton 150 participants Est. completion 2013-10 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT01370304
Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder
Not yet reported Xijing Hospital 60 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT01418209
MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms
Not yet reported Fred Hutchinson Cancer Center 339 participants Est. completion 2013-01 4 sitesOther conditions: Hot Flashes, Menopause, Vasomotor DisturbanceView official trial listing → -
Completed NCT NCT01418612
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01418625
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions
Not yet reported Torrent Pharmaceuticals LimitedOther conditions: HealthyView official trial listing → -
Completed NCT NCT01436149
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Not yet reported Shire 1262 participants Est. completion 2013-12-23 85 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01436162
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Not yet reported Shire 1105 participants Est. completion 2013-12-10 101 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT01436175
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Not yet reported Shire 1570 participants Est. completion 2014-03-27 212 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT01436643
Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2013-09 25 sites Stand-aloneOther conditions: Depression, Relapsing-remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT01441440
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 538 participants Est. completion 2014-03 63 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01443520
Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy Volunteers
Not yet reported Turku University Hospital 12 participants Est. completion 2012-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01469377
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Not yet reported Forest Laboratories 819 participants Est. completion 2013-12-12 72 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01485887
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 50 participants Est. completion 2014-01 25 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT01488266
Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
Not yet reported Korea University 90 participants Est. completion 2013-03 2 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01512459
Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 33 participants Est. completion 2006-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01516931
Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression
Not yet reported Xijing Hospital 391 participants Est. completion 2017-02-25 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Terminated NCT NCT01533753
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Not yet reported University of Wisconsin, Madison 5 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01557712
Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Not yet reported University Hospital, Grenoble 25 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01569685
The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy
Not yet reported Charlotte Sonne 207 participants Est. completion 2014-10 1 siteOther conditions: Post Traumatic Stress Disorder, DepressionView official trial listing → -
Completed NCT NCT01571453
Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
Not yet reported H. Lundbeck A/S 437 participantsOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01609348
Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)
Not yet reported Johns Hopkins University 5 participants Est. completion 2017-01 2 sitesOther conditions: Alzheimer's Disease, DepressionView official trial listing → -
Completed NCT NCT01611155
Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy
Not yet reported Mayo Clinic 50 participants Est. completion 2015-09-23 1 site Stand-aloneOther conditions: Peripheral NeuropathyView official trial listing → -
Completed NCT NCT01658228
Combination Treatment Study for Memory Impairment and Depression
Not yet reported New York State Psychiatric Institute 86 participants Est. completion 2016-01 2 sitesOther conditions: Depression, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT01715805
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Not yet reported Forest Laboratories 1022 participants Est. completion 2016-06-24 85 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01716377
Healing With Venlafaxine After Injury (HELP)
Not yet reported Rhode Island Hospital 20 participants Est. completion 2016-09 3 sitesOther conditions: Neck PainView official trial listing → -
Status unknown NCT NCT01764867
Algorithm Guided Treatment Strategies for Major Depressive Disorder
Not yet reported Shanghai Mental Health Center 1080 participants Est. completion 2014-12 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT01796132
Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
Not yet reported Centre Hospitalier Universitaire Vaudois 500 participants Est. completion 2018-12 5 sitesOther conditions: Depressive Disorder, LactationView official trial listing → -
Completed NCT NCT01824433
Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression
Not yet reported Capital Medical University 189 participants Est. completion 2017-03-16 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT01838681
Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Not yet reported H. Lundbeck A/S 1986 participants Est. completion 2016-06 107 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01838876
Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder
Not yet reported Forest Laboratories 442 participants Est. completion 2015-07-27 90 sites Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01867255
Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels
Not yet reported Mayo Clinic 10 participants Est. completion 2015-03 1 siteOther conditions: Bariatric Surgery, Gastric Bypass, Roux-en-Y Gastric BypassView official trial listing → -
Status unknown NCT NCT01896349
Interpersonal Psychotherapy for Treatment Resistant Depression
Not yet reported Hospital de Clinicas de Porto Alegre 74 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Treatment Resistant DepressionView official trial listing → -
Completed NCT NCT01916824
Effects of Treatment on Decision-making in Major Depression
Not yet reported Emory University 53 participants Est. completion 2015-12 1 siteOther conditions: Major Depressive Disorder, Healthy ControlsView official trial listing → -
Withdrawn NCT NCT01944657
Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
Not yet reported Sheppard Pratt Health System Est. completion 2015-12 1 siteOther conditions: 1. Major Depressive DisorderView official trial listing → -
Completed NCT NCT01962753
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
Not yet reported University Hospital, Tours 92 participants Est. completion 2020-01-22 10 sites Stand-aloneOther conditions: Elderly, Major DepressionView official trial listing → -
Status unknown NCT NCT01977378
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
Not yet reported, Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 300 participants 6 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT02005107
Venlafaxine PK Following Bariatric Surgery
Not yet reported North Dakota State University 12 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: Roux en Y Gastric Bypass, Sleeve GastrectomyView official trial listing → -
Status unknown NCT NCT02012504
Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
Shanghai Zhongshan Hospital 50 participants Est. completion 2014-12 1 siteOther conditions: Adverse Drug Reaction, Anxiety Disorders and SymptomsView official trial listing → -
Completed NCT NCT02051413
Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 67 participants Est. completion 2018-05 1 siteOther conditions: Major Depressive Disorder, Major Depressive EpisodeView official trial listing → -
Completed NCT NCT02058693
Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy
Not yet reported Rush University Medical Center 41 participants Est. completion 2014-12 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT02086929
Trazodone Once a Day in Major Depression Disorder
Not yet reported Aziende Chimiche Riunite Angelini Francesco S.p.A 364 participants Est. completion 2014-04 32 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT02179268
Antidepressants and Bone Mineral Density
Not yet reported Guiyang Medical University 203 participants Est. completion 2014-04Other conditions: Bone Mineral Density Quantitative Trait Locus 7View official trial listing → -
Completed NCT NCT02181231
Buprenorphine Used With Treatment Resistant Depression in Older Adults
Not yet reported, Not yet reported Washington University School of Medicine 18 participants Est. completion 2018-04-30 1 site Stand-aloneOther conditions: Major Depressive Disorder, DepressionView official trial listing → -
Completed NCT NCT02191358
YouScript IMPACT Registry
Genelex Corporation 800 participants Est. completion 2015-08 7 sitesOther conditions: Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2D6-RELATED, Drug Metabolism, Poor, CYP2C19-RELATED, Cytochrome P450 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantView official trial listing → -
Status unknown NCT NCT02237937
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
Not yet reported HolsboerMaschmeyer NeuroChemie GmbH 80 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT02263248
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Not yet reported, Not yet reported Centre for Addiction and Mental Health 56 participants Est. completion 2018-05-01 1 site Stand-aloneOther conditions: Major Depressive Disorder, DepressionView official trial listing → -
Completed NCT NCT02297126
A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 siteOther conditions: Adverse Drug ReactionView official trial listing → -
Completed NCT NCT02320240
Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
Canadian Network for Observational Drug Effect Studies, CNODES 3255526 participants Est. completion 2014-12 1 siteOther conditions: Depression, Acute Kidney InjuryView official trial listing → -
Status unknown NCT NCT02346682
Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder
Not yet reported Zhejiang Provincial Tongde Hospital 75 participants Est. completion 2017-12 1 siteOther conditions: Severe Major Depression DisorderView official trial listing → -
Completed NCT NCT02350985
Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine
Not yet reported Haseki Training and Research Hospital 73 participants Est. completion 2014-12 1 siteOther conditions: Vestibular MigraineView official trial listing → -
Terminated NCT NCT02374567
Pharmacovigilance in Gerontopsychiatric Patients
Not yet reported Hannover Medical School 407 participants Est. completion 2017-06-28 5 sites Stand-aloneOther conditions: Dementia, Depression, Schizophrenia, Psychosomatic Disorders, Anxiety DisordersView official trial listing → -
Completed NCT NCT02400346
Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
Not yet reported H. Lundbeck A/S 132 participants Est. completion 2016-06 34 sites Stand-aloneOther conditions: Major Depression DisorderView official trial listing → -
Completed NCT NCT02407704
A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise
Not yet reported Kirk Erickson, PhD 31 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Depression, Depressive Disorder, Major, Depressive Disorder, Unipolar Depression, Major Depressive DisorderView official trial listing → -
Completed NCT NCT02417064
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 346 participants Est. completion 2018-02-20 90 sites Stand-aloneOther conditions: Treatment-resistant DepressionView official trial listing → -
Completed NCT NCT02418585
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 236 participants Est. completion 2017-11-06 48 sites Stand-aloneOther conditions: Treatment-resistant DepressionView official trial listing → -
Completed NCT NCT02422186
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 139 participants Est. completion 2017-08-10 69 sites Stand-aloneOther conditions: Depressive Disorder, Treatment-ResistantView official trial listing → -
Withdrawn NCT NCT02433353
Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR
Not yet reported Bayne-Jones Army Community Hospital Est. completion 2016-01 Stand-aloneOther conditions: Posttraumatic Stress DisorderView official trial listing → -
Status unknown NCT NCT02441387
Predictors of the Outcome of Late Life Depression
University of Sao Paulo General Hospital 120 participants Est. completion 2019-07 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT02451475
Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome
Not yet reported, Not yet reported Mansoura University 75 participants Est. completion 2014-10Other conditions: FibromyalgiaView official trial listing → -
Status unknown NCT NCT02476136
Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
prof. Peter de Jonge 8800 participants Est. completion 2016-12Other conditions: Anxiety Disorders, Panic Disorder, Obsessive-compulsive Disorder, Post-traumatic Stress Disorder, Generalized Anxiety Disorder, Social Anxiety DisorderView official trial listing → -
Completed NCT NCT02493868
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 719 participants Est. completion 2018-02-16 155 sites Stand-aloneOther conditions: Depressive Disorder, Treatment-ResistantView official trial listing → -
Completed NCT NCT02497287
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 802 participants Est. completion 2017-10-28 109 sites Stand-aloneOther conditions: Treatment-resistant DepressionView official trial listing → -
Status unknown NCT NCT02590185
MetAbolism vaRiability of VEnLafaxine
Not yet reported Assistance Publique - Hôpitaux de Paris 205 participants Est. completion 2020-04 2 sitesOther conditions: Major Depressive DisordersView official trial listing → -
Completed NCT NCT02637193
A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 54 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT02655354
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
Not yet reported University of Washington 635 participants Est. completion 2019-11 24 sites Stand-aloneSubstance use disorder Other conditions: Posttraumatic Stress Disorder, Depression, Alcohol-Related Disorders, Suicidal Ideation, Mild Cognitive Impairment, Quality of Life, Pain, Wounds and Injury, Brain Injuries, Chronic DiseaseView official trial listing → -
Status unknown NCT NCT02711215
Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)
Not yet reported Medical University of Vienna 80 participants Est. completion 2020-01 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT02714400
The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
Not yet reported University of California, San Diego 20 participants Est. completion 2016-07 1 siteObstructive sleep apneaView official trial listing → -
Terminated NCT NCT02755194
"Drugs in Lactation" Analysis Consortium
The Hospital for Sick Children 68 participants Est. completion 2019-09-25 1 siteOther conditions: LactationView official trial listing → -
Status unknown NCT NCT02873234
A Study of Chinese Medicine Treating Depression
The Third Affiliated Hospital of Beijing University of Chinese Medicine 4600 participants Est. completion 2020-05 1 siteOther conditions: DepressionView official trial listing → -
Terminated NCT NCT02893371
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
University of New Mexico 1037352 participants Est. completion 2019-06-30 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Status unknown NCT NCT02934035
Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
University Medical Center Groningen 10000 participants Est. completion 2017-09Other conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT02955719
CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
Not yet reported Centre for Addiction and Mental Health 145 participants Est. completion 2020-07-16 1 site Stand-aloneOther conditions: Depression, Anxiety, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT02958527
Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1408 participants Est. completion 2020-05-11Other conditions: Depression/Depressed StateView official trial listing → -
Completed NCT NCT02977299
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Not yet reported Massachusetts General Hospital 278 participants Est. completion 2022-04-24 13 sites Stand-aloneOther conditions: Treatment Resistant Major Depressive DisorderView official trial listing → -
Completed NCT NCT03126188
Study of the Effect of Antidepressant Drugs on Neurotrophic Factors in Patients With Depression
All India Institute of Medical Sciences, Bhubaneswar 105 participants Est. completion 2018-02-28 1 siteOther conditions: Depressive EpisodeView official trial listing → -
Terminated NCT NCT03274817
A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
Not yet reported NYU Langone Health 5 participants Est. completion 2019-09-25 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT03294525
Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
Peking University 400 participants Est. completion 2022-08 1 siteOther conditions: Affective DisorderView official trial listing → -
Completed NCT NCT03321526
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Not yet reported Janssen Research & Development, LLC 107 participants Est. completion 2019-06-27 50 sites Stand-aloneOther conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT03434041
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Not yet reported Janssen Research & Development, LLC 252 participants Est. completion 2021-04-13 30 sites Stand-aloneOther conditions: Depressive Disorder, Treatment-ResistantView official trial listing → -
Completed NCT NCT03464383
Anxiety and Depression in Epilepsy: A Treatment Study
Not yet reported Wake Forest University Health Sciences 69 participants Est. completion 2019-09-20 1 site Stand-aloneOther conditions: Anxiety, Depression, EpilepsyView official trial listing → -
Withdrawn NCT NCT03522987
Anxiety and Depression in Epilepsy: A Pilot Treatment Study
Not yet reported Wake Forest University Health Sciences Est. completion 2018-05 1 site Stand-aloneOther conditions: Anxiety, Depression, EpilepsyView official trial listing → -
Completed NCT NCT03538691
A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 1149 participants Est. completion 2022-07-29 1 site Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT03574792
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Not yet reported Roswell Park Cancer Institute 62 participants Est. completion 2021-11-11 1 site Stand-aloneOther conditions: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8View official trial listing → -
Completed NCT NCT03588572
The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study
Not yet reported Guangzhou General Hospital of Guangzhou Military Command 43 participants Est. completion 2019-08-01 2 sites Stand-aloneCardiovascular disease Other conditions: Subcortical AphasiaView official trial listing → -
Completed NCT NCT03920475
The Role of Inflammatory Processes in Development and Treatment of Depression
Kliniken Essen-Mitte 104 participants Est. completion 2018-03-06Other conditions: Depressive Disorder, Depression, InflammationView official trial listing → -
Status unknown NCT NCT04207385
Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine
Not yet reported Xijing Hospital 160 participants Est. completion 2021-11-20 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Completed NCT NCT04218123
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
Not yet reported, Not yet reported Medical University of South Carolina 40 participants Est. completion 2023-09-14 1 site Stand-aloneOther conditions: Meniere DiseaseView official trial listing → -
Status unknown NCT NCT04229602
Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers
Not yet reported Beijing Tongren Hospital 28 participants Est. completion 2020-07-02 1 site Stand-aloneOther conditions: Bioequivalence StudyView official trial listing → -
Status unknown NCT NCT04396314
Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial
Not yet reported Universitat de Lleida 54 participants Est. completion 2022-04-30Other conditions: PostTraumatic Stress DisorderView official trial listing → -
Completed NCT NCT04437485
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
Not yet reported Indiana University 46 participants Est. completion 2022-08-29 1 site Stand-aloneType 2 diabetesPrediabetes Other conditions: Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms, Insulin ResistanceView official trial listing → -
Completed NCT NCT04446039
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
Pfizer 370212 participants Est. completion 2022-11-03 1 siteOther conditions: Major DepressionView official trial listing → -
Completed NCT NCT04478526
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
Not yet reported Dr. Nazanin Alavi 115 participants Est. completion 2021-05-01 1 site Stand-aloneOther conditions: Generalized Anxiety DisorderView official trial listing → -
Completed NCT NCT04597190
Sequenced Treatment Effectiveness for Posttraumatic Stress
Not yet reported University of Washington 700 participants Est. completion 2024-08-01 15 sitesOther conditions: PTSDView official trial listing → -
Completed NCT NCT04639193
Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea
Not yet reported University of California, San Diego 20 participants Est. completion 2022-01-27 2 sites Stand-aloneObstructive sleep apneaView official trial listing → -
Status unknown NCT NCT04653337
Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression
Not yet reported Xijing Hospital 56 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Suicidal Ideation, DepressionView official trial listing → -
Status unknown NCT NCT04664088
Acupuncture for Prophylaxis of Vestibular Migraine
Not yet reported Affiliated Hospital of Jiaxing University 72 participants Est. completion 2023-12-31 1 siteOther conditions: Vestibular MigraineView official trial listing → -
Status unknown NCT NCT04737967
The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy
Not yet reported, Not yet reported Mendel AI 60 participants Est. completion 2021-10-01 1 site Stand-aloneOther conditions: Oncology Pain, Chemotherapy-induced Peripheral NeuropathyView official trial listing → -
Completed NCT NCT04747314
Treating Negative Affect in Low Back Pain Patients
Not yet reported Ajay Wasan, MD, Msc 308 participants Est. completion 2024-12-20 3 sitesOther conditions: Chronic Low Back Pain, Negative AffectivityView official trial listing → -
Status unknown NCT NCT04748276
Tracking Response to Antidepressants in Advance of Investigational Trials
Adams Clinical 400 participants Est. completion 2023-12-31 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT04806230
Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study
Linkoeping University 81 participants Est. completion 2013-09-30 1 siteOther conditions: Pharmacokinetics, Antidepressive Agents, PregnancyView official trial listing → -
Active, not recruiting NCT NCT04961190
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
Not yet reported University of Pennsylvania 304 participants Est. completion 2026-11-01 7 sitesOther conditions: Posttraumatic Stress DisorderView official trial listing → -
Withdrawn NCT NCT04965272
A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone
Not yet reported AbbVie Est. completion 2021-08-24 36 sites Stand-aloneOther conditions: Generalized Anxiety DisorderView official trial listing → -
Suspended NCT NCT04973930
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer
Not yet reported New York State Psychiatric Institute 20 participants Est. completion 2025-12-31 1 siteOther conditions: Major Depressive Disorder, Breast Cancer, VenlafaxineView official trial listing → -
Withdrawn NCT NCT04977271
Mood Disorders in Head and Neck Cancer Patients
Not yet reported University of Alabama at Birmingham Est. completion 2024-10-01 Stand-aloneOther conditions: Depressive Disorder, Head and Neck CancerView official trial listing → -
Completed NCT NCT05023278
The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
Not yet reported University of California, San Francisco 100 participants Est. completion 2025-03-31 1 site Stand-aloneOther conditions: Acute Pain, Chronic Pain, Knee Pain Chronic, Neuropathic PainView official trial listing → -
Status unknown NCT NCT05104918
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
Not yet reported Scotmann Pharmaceuticals 500 participants Est. completion 2022-06Other conditions: Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT05280015
Microbiotherapy in Characterized Depressive Disorder
Not yet reported Centre Hospitalier Universitaire de Besancon 92 participants Est. completion 2024-12 4 sitesOther conditions: Depression, Depressive Disorder, Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT05569031
Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
Not yet reported Zagazig University 52 participants Est. completion 2022-06-15 1 siteOther conditions: Opiate Withdrawal SyndromeView official trial listing → -
Withdrawn NCT NCT05724849
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Not yet reported Vanderbilt University Medical Center Est. completion 2026-08-01 Stand-aloneOther conditions: Head and Neck Cancer, DepressionView official trial listing → -
Not yet recruiting NCT NCT05737511
Efficacy of Hydroxyzine for Patients With Panic Disorder
Not yet reported Sultan Qaboos University 80 participants Est. completion 2026-12-30Other conditions: Panic DisorderView official trial listing → -
Status unknown NCT NCT05777876
Early Identification of TRD and Construction and Clinical Validation of NTBS Precision Technology
Not yet reported First Affiliated Hospital of Zhejiang University 400 participants Est. completion 2025-12-31 1 siteOther conditions: Treatment-Resistant DepressionView official trial listing → -
Status unknown NCT NCT05875610
Preventive Approach Using Venlafaxine
Not yet reported Mit Ghamr Oncology Center 60 participants Est. completion 2023-12-01 1 site Stand-aloneOther conditions: Peripheral Neuropathy Due to ChemotherapyView official trial listing → -
Status unknown NCT NCT05884268
Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy
Not yet reported, Not yet reported Mansoura University 60 participants Est. completion 2024-01-30Other conditions: Laparoscopic CholecystectomyView official trial listing → -
Status unknown NCT NCT05889234
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
First Affiliated Hospital of Chongqing Medical University 180 participants Est. completion 2026-01-01 1 siteOther conditions: Major Depressive Disorder, Magnetic Resonance Imaging, Electroconvulsive TherapyView official trial listing → -
Completed NCT NCT05931965
Combination Therapy of Different Antidepressants With Dietary Supplements
Not yet reported Riphah International University 88 participants Est. completion 2023-08-31 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT05952713
Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 73336 participants Est. completion 2023-07-01 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT06049797
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Astellas Pharma Global Development, Inc. 999 participants Est. completion 2026-05-07 48 sitesOther conditions: Hot FlashesView official trial listing → -
Status unknown NCT NCT06131268
The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 30 participants Est. completion 2024-04-01 1 site Stand-aloneOther conditions: Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, ModerateView official trial listing → -
Completed NCT NCT06278038
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder
Not yet reported First Affiliated Hospital of Zhejiang University 84 participants Est. completion 2024-11-19 1 siteOther conditions: Major Depression DisorderView official trial listing → -
Completed NCT NCT06295562
Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea
Not yet reported China Medical University Hospital 45 participants Est. completion 2025-10-22 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT06659094
Reducing Maximal Support in OCD: Efficacy of Stepped-Care Online CBT
Not yet reported Shanghai Mental Health Center 95 participants Est. completion 2025-12-30 1 site Stand-aloneOther conditions: Obsessive Compulsive Disorder (OCD)View official trial listing → -
Completed NCT NCT06965569
Multiple Ascending Dose Phase 1 Study of ALA-3000
Not yet reported Alar Pharmaceuticals Inc. 37 participants Est. completion 2025-12-30 4 sites Stand-aloneOther conditions: Treatment Resistant DepressionView official trial listing → -
Not yet recruiting NCT NCT07296770
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
Not yet reported University of California, San Francisco 474 participants Est. completion 2029-12-01 1 siteOther conditions: Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After SurgeryView official trial listing → -
Active, not recruiting NCT NCT07359248
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
Not yet reported Tongji Hospital 432 participants Est. completion 2028-01-01 1 siteOther conditions: Tension Type HeadacheView official trial listing → -
Not yet recruiting NCT NCT07497282
Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis
Not yet reported Ain Shams University 70 participants Est. completion 2026-12-26 Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT07531173
Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 8688 participants Est. completion 2027-12-31Chronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07655440
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Not yet reported Stanford University 120 participants Est. completion 2031-07Other conditions: Migraine Associated Vertigo, Tinnitus, Migraine, Vestibular MigraineView official trial listing → -
Not yet recruiting NCT NCT07698626
Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome
Not yet reported Beijing Tiantan Hospital 140 participants Est. completion 2027-12-31 Stand-aloneOther conditions: Bladder Pain Syndrome, Chronic Pelvic Nociplastic Pain, Interstitial CystitisView official trial listing → -
Not yet recruiting NCT NCT07737158
Venlafaxine for Non-specific Low Back Pain
Not yet reported Beijing Tiantan Hospital 228 participants Est. completion 2028-12-30 1 site Stand-aloneOther conditions: Non-specific Low Back Pain, Pain ManagementView official trial listing → -
Not yet recruiting NCT NCT07738497
Biomarkers and Pharmacogenomics for Precision Depression Therapy
Not yet reported The Fourth Affiliated Hospital of Zhejiang University School of Medicine 220 participants Est. completion 2029-01-19 Stand-aloneOther conditions: Depression / Major Depressive DisorderView official trial listing → -
Not yet recruiting NCT NCT07795593
Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy
Not yet reported University of Michigan 600 participants Est. completion 2031-10 23 sites Stand-aloneOther conditions: Painful Diabetic Neuropathy (PDN), Diabetic NephropathiesView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Venlafaxine Hydrochloride, Venlafaxine, Effexor, Trevilor, Vandral, Dobupal
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.